Меню
Идёт набор NCT06244953

Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care

Без фазы С лечением Heart Failure

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: TIER-HF-PC, Usual Care.
Кому может быть актуально
Состояния в реестре: Heart Failure. Базовые параметры: 21 лет — 99 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Сингапур
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

There is evidence for the effectiveness and feasibility of the individual components of TIER-HF-PC, however there is a need to test how these individual components interact to allow the researchers to deliver TIER-HF-PC as a model of care in its totality. In the short term, this study will assess if TIER-HF-PC is beneficial for patients and caregivers.

Подробное описание

Timely Interventions to Enable and Reach patients with Heart Failure, and their caregivers with Palliative Care, or TIER-HF-PC, is a novel model of palliative care, designed to address gaps of palliative care delivery for patients with advanced heart failure, and their caregivers.

TIER-HF-PC is a service, led by a health coach, with support by a palliative care physician. This health coach will actively screen and monitor patients for problems, and then match the type and intensity of palliative care treatments to the severity of problems reported. The health coach will also facilitate processes for patients to initiate contact with health care providers should problems arise. This decreases the overall burden on palliative care services, enabling a scalable and more cost-effective model of care for a larger number of patients. The service will also utilize a proactive approach to care, increasing self-care skills and understanding of disease and treatment options. Earlier palliative care support will enable problems to be managed actively before they escalate into crises.

Overall aim: To test the effectiveness and implementation of the interacting components of TIER-HF-PC.

Specific aim 1a: To evaluate the impact of TIER-HF-PC on patients. The primary outcome is patient quality-of-life at 24 weeks, measured on the Kansas City Cardiomyopathy Questionnaire. Secondary outcomes include patient anxiety, depression, coping, spirituality, healthcare utilization, survival, and cost-effectiveness of TIER-HF-PC.

Specific aim 1b: To evaluate the impact of TIER-HF-PC on caregivers. Outcomes evaluated include caregiver quality-of-life.

\- Hypothesis 1: The researchers hypothesize that TIER-HF-PC will be superior to usual care, in improving patient and caregiver quality-of-life.

Specific aim 2: To evaluate the implementation outcomes of TIER-HF-PC.

\- Hypothesis 2: The researchers hypothesize that participants will be satisfied with the TIER-HF-PC service, though modifications might be needed for fine-tuning of the appropriateness and timeliness of care provision in TIER-HF-PC. They will evaluate these implementation outcomes through a validated service evaluation survey and semi-structured interviews. Fidelity to study protocols will be assessed through audits of case notes and study processes.

Вмешательства

  • Другое TIER-HF-PC
    The patient will be assigned to one of the three levels of care which is determined by the results given by Distress Thermometer (DT) and the Integrated Palliative Care Outcome Scale (IPOS).
  • Другое Usual Care
    Patient continues on clinical care by his/her cardiologist. If the cardiologist picks up their symptoms or other concerns, he/or can be referred to a specialist palliative care physician by the cardiologist.

Первичные конечные точки

  • Patient quality of life (QOL) per the KCCQ-12 Questionnaire [Срок оценки: Every 8 weeks from baseline, till the point of patient death, or till week 48, whichever is earlier.]
  • Patient quality of life (QOL) per the EUROQOL EQ-5D-5L Questionnaire [Срок оценки: Baseline, 8 weeks, 16 weeks, and 24 weeks.]
  • Caregiver Quality of Life (QOL) [Срок оценки: Every 8 weeks from baseline, till the point of patient death, or till week 48, whichever is earlier.]
Вторичные конечные точки (8)
  • Acceptability of TIER-HF-PC from patient and caregiver participants - through completion of the client satisfaction questionnaire (CSQ-4) [Срок оценки: At Week 25.]
  • Acceptability of TIER-HF-PC from patient and caregiver participants - through semi-structured interviews [Срок оценки: From Week 25 onwards, up to Week 48.]
  • Patient anxiety and depression [Срок оценки: Baseline, 8 weeks, 16 weeks, and 24 weeks.]
  • Patient and Caregiver Spirituality [Срок оценки: Baseline, 8 weeks, 16 weeks, and 24 weeks.]
  • Patient and Caregiver Coping [Срок оценки: Baseline, 8 weeks, 16 weeks, and 24 weeks.]
  • Assessment of impact of TIER-HF-PC on healthcare utilization [Срок оценки: Week 1 to Week 24.]
  • Healthcare cost analysis [Срок оценки: Up to 24 weeks.]
  • Survival analysis [Срок оценки: Up to 48 weeks.]

Критерии участия

Критерии включения

  • Patients:
  • 21 years or older and
  • able to communicate in English/Chinese/Malay and
  • be of stage C or D heart failure, as defined by American College of Cardiology/American Heart Association (ACC/AHA) classification system and
  • have functional limitation of New York Heart Association (NYHA) functional status of at least 2 or more and
  • be deemed by their cardiologist's clinical judgement to have an expected prognosis of at least 6 months survival, and
  • have had a heart failure related hospitalization event (e.g. symptomatic decompensated heart failure) within 6 months prior to recruitment and
  • have a phone that allows telecommunication.
  • Caregivers must meet all the following inclusion criteria to be eligible for the study :
  • direct, unpaid, family caregiver of the patient;
  • self-reported by the patient to be the main person to be either:
  • responsible for up to 4 hours a day of caregiving tasks
  • and/or decision maker/spokesperson with the medical team
  • Caregiver may or may not live in the same residence as the patient.
  • Caregivers must be 21 years and above.
  • Able to communicate in English/Chinese/Malay.

Критерии исключения

  • Patients:
  • have cognitive impairment (e.g., dementia)
  • have severe, untreated, active mental illness (e.g., major depressive disorder)
  • have ventricular assist device implant.
  • have non-reversible hearing or visual loss or
  • are active drug abuser or
  • already known to a palliative care service.
  • Caregivers who meet any of the exclusion criteria at baseline will be ineligible for the study:
  • have cognitive impairment (e.g., dementia) or
  • have severe, untreated, active mental illness (e.g., major depressive disorder)
  • have non-reversible hearing or visual loss.
  • are active drug abuser or
  • are a domestic helper for the patient

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Организация здравоохранения

Центры проведения

Сингапур · 4 центра
  • National Heart Centre Singapore — Singapore
  • Sengkang General Hospital — Singapore
  • Khoo Teck Puat Hospital — Singapore
  • National Cancer Centre, Singapore — Singapore

Публикации

  • Neo SH, Yu K, Lee CF, Cheung YB. Interventions to enable and reach patients with heart failure and their caregivers, with palliative care (TIER-HF-PC): a study protocol of a two-armed parallel group, open label randomised controlled trial that evaluates the effectiveness of a tiered model of palliative care in tertiary cardiac institutes in Singapore. BMJ Open. 2025 Mar 27;15(3):e100581. doi: 10.1 PMID 40147986

Идентификаторы

NCT: NCT06244953 · TIER-HF-PC

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗